KH NEOCHEM CO., LTD. Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
February 7, 2022
Consolidated Financial Results | |
for the Fiscal Year Ended December 31, 2021 | |
(Under Japanese GAAP) | |
Company name: | KH Neochem Co., Ltd. |
Listing: | Tokyo Stock Exchange |
Securities code: | 4189 |
URL: | https://www.khneochem.co.jp/en/ |
Representative: | Michio Takahashi, Representative Director, President & Chief Executive Officer |
Inquiries: | Masaya Hamamoto, Board Director, Senior Corporate Officer & Chief Financial Officer |
Telephone: | +81-3-3510-3550 |
Scheduled date of ordinary general meeting of shareholders:
Scheduled date to commence dividend payments:
Scheduled date to file annual securities report:
Preparation of supplementary material on financial results:
Holding of financial results briefing:
(Yen amounts are rounded down to millions, unless otherwise noted.)
1. Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (from January 1, 2021 to December 31, 2021)
(1) Consolidated Operating Results | (Percentages indicate year-on-year changes.) | ||||||||||||||||||
Net sales | Operating income | Ordinary income | Net income attributable | ||||||||||||||||
to owners of parent | |||||||||||||||||||
Fiscal year ended | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |||||||||||
December 31, 2021 | 117,110 | 51.4 | 19,685 | 248.9 | 19,809 | 252.0 | 13,691 | 238.3 | |||||||||||
December 31, 2020 | 77,332 | (17.9) | 5,642 | (41.0) | 5,627 | (43.1) | 4,046 | (41.5) | |||||||||||
Note: Comprehensive income For the fiscal year ended December 31, 2021: | ¥13,955 million [204.2 %] | ||||||||||||||||||
For the fiscal year ended December 31, 2020: | ¥4,586 million | [(37.5)%] | |||||||||||||||||
Basic earnings | Diluted earnings | Return on equity | Ratio of ordinary | Ratio of operating | |||||||||||||||
per share | per share | income to total assets | income to net sales | ||||||||||||||||
Fiscal year ended | Yen | Yen | % | % | % | ||||||||||||||
December 31, 2021 | 368.95 | － | 27.9 | 18.2 | 16.8 | ||||||||||||||
December 31, 2020 | 109.12 | 109.02 | 9.6 | 5.7 | 7.3 | ||||||||||||||
Reference: | Share of profit of entities accounted for using equity method | ||||||||||||||||||
For the fiscal year ended December 31, 2021: ¥258 million | |||||||||||||||||||
For the fiscal year ended December 31, 2020: ¥132 million | |||||||||||||||||||
(2) Consolidated Financial Position | |||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | ||||||||||||||||
As of | Millions of yen | Millions of yen | % | Yen | |||||||||||||||
December 31, 2021 | 122,069 | 57,505 | 45.0 | 1,480.27 | |||||||||||||||
December 31, 2020 | 95,508 | 45,884 | 45.4 | 1,168.62 | |||||||||||||||
Reference: | Equity As of December 31, 2021: | ¥54,917 million | |||||||||||||||||
As of December 31, 2020: | ¥43,380 million |
(3) Consolidated Cash Flows
Cash flows from | Cash flows from | Cash flows from | Cash and cash equivalents | |
operating activities | investing activities | financing activities | at end of period | |
Fiscal year ended | Millions of yen | Millions of yen | Millions of yen | Millions of yen |
December 31, 2021 | 17,402 | (4,395) | (5,168) | 16,934 |
December 31, 2020 | 6,931 | (11,182) | (4,530) | 9,066 |
2. Cash Dividends
Annual dividends per share | Total cash | Dividend | Dividend on | |||||
dividends | payout ratio | net assets ratio | ||||||
First | Second | Third | Fiscal | Total | ||||
quarter-end | quarter-end | quarter-end | year-end | (Annual) | (Consolidated) | (Consolidated) | ||
Fiscal year ended | Yen | Yen | Yen | Yen | Yen | Millions | % | % |
of yen | ||||||||
December 31, 2020 | － | 30.00 | － | 30.00 | 60.00 | 2,228 | 55.0 | 5.3 |
December 31, 2021 | － | 30.00 | － | 45.00 | 75.00 | 2,786 | 20.3 | 5.7 |
Fiscal year ending | ||||||||
December 31, 2022 | － | 42.50 | － | 42.50 | 85.00 | 27.4 | ||
(Forecast) |
3. Forecasts of Consolidated Financial Results for the Fiscal Year Ending December 31, 2022 (from January 1, 2022 to December 31, 2022)
(Percentages indicate changes from the previous corresponding period.)
Net income attributable | Basic | |||||||||
Net sales | Operating income | Ordinary income | earnings | |||||||
to owners of parent | ||||||||||
per share | ||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | ||
Six months | ||||||||||
ending | 57,600 | － | 6,800 | (12.8) | 6,900 | (14.5) | 4,900 | (13.2) | 132.07 | |
June 30, 2022 | ||||||||||
Full year | 123,300 | － | 16,100 | (18.2) | 16,400 | (17.2) | 11,500 | (16.0) | 309.97 | |
Note: The percentage changes from the previous year of net sales are not listed, because the above forecasts of consolidated financial results are after the adoption of the ASBJ Guidance No. 29 "Accounting Standard for Revenue Recognition" which will be applied from the beginning of the fiscal year ending December 31, 2022.
* Notes
- Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in the change in scope of consolidation): None
- Changes in accounting policies, changes in accounting estimates, and restatement
-
Changes in accounting policies due to revisions to accounting standards and other regulations: None
② Changes in accounting policies due to other reasons: None
③ Changes in accounting estimates: None
④ Restatement: None
-
Changes in accounting policies due to revisions to accounting standards and other regulations: None
- Number of issued shares (common shares)
- Total number of issued shares at the end of the period (including treasury stock)
As of December 31, 2021 | 37,149,400 shares |
As of December 31, 2020 | 37,149,400 shares |
- Number of treasury stock at the end of the period
As of December 31, 2021 | 50,004 shares |
As of December 31, 2020 | 28,379 shares |
(Note) Total number of treasury stock at the end of the period includes the number of the Company's shares held by the Company's Board Benefit Trust (BBT) (December 31, 2021: 49,600 shares, December 31, 2020: 28,000 shares).
- Average number of shares outstanding during the period
Fiscal year ended December 31, 2021 | 37,108,058 shares |
Fiscal year ended December 31, 2020 | 37,079,495 shares |
(Note) The number of treasury stock deducted in the calculation of Average number of shares during the period includes the number of the Company's shares held by Board Benefit Trust (BBT) (Fiscal year ended December 31, 2021: 40,947 shares, Fiscal year ended December 31, 2020: 21,316 shares).
(Reference) Overview of Non-Consolidated Financial Results
1. Non-Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (from January 1, 2021 to December 31, 2021)
(1) Non-Consolidated Operating Results | (Percentages indicate year-on-year changes.) | |||||||||||
Net sales | Operating income | Ordinary income | Net income | |||||||||
Fiscal year ended | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | ||||
December 31, 2021 | 109,410 | 54.4 | 18,769 | 265.3 | 18,783 | 254.5 | 13,190 | 229.1 | ||||
December 31, 2020 | 70,845 | (18.8) | 5,138 | (42.6) | 5,298 | (43.3) | 4,007 | (40.3) | ||||
Basic earnings | Diluted earnings | |||||||||||
per share | per share | |||||||||||
Fiscal year ended | Yen | Yen | ||||||||||
December 31, 2021 | 355.45 | － | ||||||||||
December 31, 2020 | 108.08 | 107.98 |
(2) Non-Consolidated Financial Position
Total assets | Net assets | Equity ratio | Net assets per share | ||
As of | Millions of yen | Millions of yen | % | Yen | |
December 31, 2021 | 115,796 | 51,298 | 44.3 | 1,382.72 | |
December 31, 2020 | 90,062 | 40,541 | 45.0 | 1,092.13 | |
Reference: Equity As of December 31, 2021: | ¥51,298 million | ||||
As of December 31, 2020: | ¥40,541 million |
<Reasons for differences from the previous fiscal year of non-consolidated financial results>
The previous fiscal year (FY2020), there were substantial decrease of sales volume and decline of sales prices due to slumping demand in Japan and overseas caused by the spread of COVID-19. On the other hand, the current fiscal year (FY2021), net sales and profits significantly improved by significant expansion of the demand for our products, tighten of the supply-demand balance and soaring of the overseas markets.
These resulted in differences between the results of FY2020 and the results of FY2021.
- Financial results reports are exempt from audit conducted by certified public accountants or an audit corporation.
-
Proper use of earnings forecasts, and other special matters
Earnings forecasts and other forward-looking statements included in this document are based on the information currently available to the Company and certain assumptions deems reasonable, and the Company makes no commitments regarding their achievability. Actual business results may differ materially from the forecast due to variety of factors. - How to obtain the financial results briefing materials
The Company is scheduled to hold a web conference for institutional investors and securities analysts on February 7, 2022. The materials of the web conference will be posted on the Company's website.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
KH Neochem Co. Ltd. published this content on 07 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 February 2022 06:07:03 UTC.
